Hyro
15 known investors
Plug-and-play conversational AI platform enabling voice and chat interactions with information across digital channels.
Also known as Hyro AI
Founders & leadership

Investors · 15
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountgrowth roundOct 2025Source ↗
- Undisclosed amountSeries B extensionDec 2024 · 2 sources
Healthier Capital (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Hyro operates what it calls a Responsible AI Agent Platform for healthcare, deploying voice and chat AI agents that automate patient-facing communications across call centers, websites, mobile apps, SMS and messaging channels. The platform's stated skills include physician search, appointment scheduling and management, prescription (Rx) management, FAQ resolution, IT help desk support, smart call routing, GPT-powered site search ("Spot"), and outbound/proactive communications via a product launched in 2025 called Proactive Px. Hyro reports that its agents resolve up to 85% of routine patient interactions such as registration, routing, scheduling and prescription management, with contextual escalation to live human agents when needed.
The company positions its offering as an "adaptive communications" platform: rather than requiring manually built intent-based conversational flows, Hyro ingests data from multiple sources, maps it into a knowledge graph, and layers natural language understanding on top, which it says enables self-learning from deployment onward and go-live in as little as three days. A Conversational Intelligence / Patient Intelligence Dashboard layer surfaces conversational metrics, call drivers, access gaps and operational performance across channels, benchmarked against peer health systems. Hyro emphasizes three pillars for patient-facing deployment — explainability of response logic, control over which data sources may be used in order to limit hallucinations, and regulatory compliance including HIPAA and PII/PHI redaction.
Hyro was founded in 2018 by Israel Krush (CEO) and Rom Cohen, who is identified as COO and Co-Founder on the company's leadership page and as CIO and Co-Founder in the company's 2025 funding release. Other named leaders include CTO Nitzan Bar, CMO Aaron Bours, and Chief of Staff & VP HR Maya Agmon. The company reports roughly 150 employees ("170 SuperHyros and counting" is also cited on its about page) across two offices, with staff from 15 countries.
Founding story
Hyro was founded in 2018 by Israel Krush and Rom Cohen. The company states its name derives from "hieroglyphics" and describes itself as a language company, with a mission to simplify interactions across digital channels.
Business model
Hyro sells an enterprise software platform to healthcare organizations, deploying AI voice and chat agents that integrate with customers' existing EMR, CRM, telephony and provider-directory systems. The company frames value in terms of automation rate, ROI, reduced operational costs and reduced call-center load, and describes a plug-and-play deployment requiring no IT build or manual workflow configuration, with expansion by adding further use cases and channels over time.
Sold as a business-to-business enterprise platform to health systems, health plans and clinic groups; specific pricing terms are not disclosed publicly.
Traction
Company materials report more than 45 health systems deployed, over 30 million patients engaging with its chat and voice agents in the United States, more than 1,000 AI agents in production, 50 million-plus (site) to 100 million-plus (about page) successful conversations, 120 million-plus minutes saved, and more than 1,100 legacy chatbots replaced. Customer-reported outcomes cited include $1,000,000 in automated workflow savings at Baptist Health, roughly 4,000 hours saved per month and 8.8x ROI at one system, 56% lower daily call abandonment and 58% shorter wait times, 90% chat resolution, and a 47% increase in appointments booked online. Total disclosed funding stands at $95 million following the October 2025 round.
Latest developments
In October 2025 Hyro announced $45 million in growth funding led by Healthier Capital, with Norwest, Define Ventures, existing investors, and new strategic investors Bon Secours Mercy Health and ServiceNow Ventures; the company said the round doubled its valuation and brought total funding to $95 million, and that proceeds would accelerate development of administrative, operational and clinical AI agents. It also launched Proactive Px for outbound and bi-directional patient communications, and was named No. 677 on the 2026 Inc. 5000 list of fastest-growing private U.S. companies. Recent company publications focus on agentic AI governance, benchmark reports on healthcare call center and voice agent performance, and a Care Intelligence offering that benchmarks operational signals against peer health systems.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Hyro competes in the healthcare conversational and voice AI segment against newer AI voice startups and CCaaS providers, and positions itself as replacing legacy chatbots and IVR systems. It cites healthcare-specific data ingestion, workflow knowledge and deep EMR interoperability (notably Epic) as differentiators, and an investor in the 2025 round described the company as positioned to become an AI communications layer for healthcare. Company materials list recognition including CB Insights Digital Health 150 (2022), a Gartner-style "Cool Vendor" designation (2022), and awards for conversational AI solution and call center automation (2022).
Positioned on healthcare-native design rather than generic conversational AI: multi-modal data ingestion, healthcare workflow knowledge, exclusive/secure API integrations with EHR vendors such as Epic, a hybrid LLM plus small-language-model and knowledge-graph architecture, and responsible-AI controls (explainability, restricted knowledge sources, HIPAA compliance). The company also claims no requirement to build or maintain conversational flows, deployment in as little as three days, and time-to-value 173 days faster than the next-fastest alternative.
Technology
Hyro combines large language models with a proprietary conversational engine that includes healthcare-specific small language models (SLMs) and knowledge graphs purpose-built for healthcare. Data is scraped and ingested from multiple customer sources, mapped into a knowledge graph and augmented with natural language understanding, avoiding manually built decision trees. Agents connect to EHRs/EMRs (including via Epic's advanced APIs), CRMs such as Salesforce, databases, provider directories and telephony systems through secure API calls to complete tasks autonomously, with defined and restricted data sources intended to limit hallucinations, full explainability of response logic, HIPAA compliance and PII/PHI redaction.
Go-to-market
Direct enterprise sales to health systems supported by demo requests, case studies with named customers, benchmark and survey reports, webinars for healthcare CIOs, a podcast featuring healthcare executives, and content marketing. The company also expands within existing accounts by adding channels and use cases, and has drawn strategic investment from a customer (Bon Secours Mercy Health) and from ServiceNow Ventures.
Primarily U.S. hospital and health system provider organizations — including their call centers, patient access, IT and operations teams — with increasing adoption by health plans and mid-sized specialty and clinic groups. Named clients include Intermountain Health, Baptist Health (Jacksonville), Hackensack Meridian Health, Bon Secours Mercy Health, Sutter Health, Tampa General Hospital, Prisma Health, Piedmont Healthcare and Endeavor Health.
Geography
Headquartered activity centered on New York (source of its funding announcements) with two offices and employees from 15 countries; customer deployments are described as across the United States.
History
Founded in 2018, Hyro built an adaptive communications platform for automating voice and chat interactions, later focusing on healthcare providers. It raised a $35 million Series B, followed by a December 2024 Series B extension aimed in part at expanding into health plans and mid-sized clinics, and in October 2025 announced a $45 million strategic growth round positioned between Series B and Series C, doubling its valuation and bringing total funding to $95 million. Around the same period it launched Proactive Px for bi-directional inbound and outbound patient communications and added health system customers including Sutter Health, Tampa General Hospital, Prisma Health and Piedmont Healthcare. The company was subsequently ranked No. 677 on the 2026 Inc. 5000 list.
Risks & controversies
Operating in patient-facing healthcare communications exposes the company to HIPAA and evolving data-protection regulation, risks of inaccurate or hallucinated model outputs (which it addresses via restricted data sources and explainability controls), and dependence on integrations with third-party EHR, CRM and telephony systems. Its own materials note that health system leaders view governance as the principal bottleneck to agentic AI adoption, and the market is crowded with AI voice startups and CCaaS incumbents.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 6
by search overlapCompanies competing with Hyro for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 5
launches, deals, and filingsHyro was ranked No. 677 on the 2026 Inc. 5000 list of fastest-growing private companies in America.
Hyro announced $45 million in new growth funding led by Healthier Capital, with participation from Norwest, Define Ventures and other existing investors, plus new strategic investments from client Bon Secours Mercy Health and ServiceNow Ventures. The company said the round doubled its valuation and brought total funding to $95 million, and came 10 months after its previous raise. Proceeds are earmarked for administrative, operational and clinical AI agent development.
$45M source ↗
Bon Secours Mercy Health, a Hyro client of more than five years, said it would further expand Hyro's AI-powered scheduling capabilities in its call center, alongside a strategic investment via Accrete Health Partners.
Hyro launched Proactive Px, extending its platform to 360-degree bi-directional inbound and outbound patient communications.
Company materials list 2022 recognitions: Digital Health 150, Cool Vendor, Conversational AI Solution, and Call Center Automation awards.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Hyrohyro.ai · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Hyro do?
- Hyro is a healthcare-focused AI agent platform automating patient voice and chat interactions across call centers, websites and SMS.
- Who founded Hyro?
- Hyro was founded by Israel Krush, Rom Cohen.
- Who are Hyro's investors?
- Hyro's investors include Black Opal Ventures, Dorm Room, Entrepreneurs Roundtable Accelerator (ERA), Hanaco Venture Capital, Healthier Capital, K20 Fund, Mindset Venture, Norwest Venture Partners and 4 more.




